News Coverage 10.17.19 By: Ryan Cross Share on Twitter Share on Facebook Share on LinkedIn Parker Institute spin-off launches to make CRISPR-edited cell therapies Related Announcement, Partner Highlight, Press Release PICI, Immunai to Build Landmark Cancer Dataset Announcement, Our Impact PICI at AACR 2025: Data, Direction, Impact Announcement, Press Release Dr. Ira Mellman Joins PICI as President of Research